close
Enquiry IconContact Us
Logo
  • Choose License Type

Global Bacterial & Viral Specimen Collection Market, by Product Type (Bacterial Specimen Collection (Swabs, Bacterial Transport Media, Blood Collection Kits, and Others), Viral Specimen Collection (Swabs, Viral Transport Media, Blood Collection Kits, and Others)), by Application (Diagnostics and Research), by End User (Hospitals, Clinics, Diagnostic Laboratories, Research or Academic Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 17.50 billion in 2021, and is expected to exhibit a CAGR of 14% during the forecast period (2021-2028).

Market players involved in launching new products, is expected to help in boosting growth of the global bacterial & viral specimen collection market. For instance, on October 29, 2020, Sengenics, the Functional Proteomics Company, announced the release of SEROMAX, a sample collection kit that requires only a pinprick of blood to quantify antibodies or autoantibodies.

Market players involved in new product approvals, is expected to propel the growth of global bacterial & viral specimen collection market. For instance, on March 24, 2020, BioMérieux, a global leader in in vitro diagnostics, announced that its subsidiary, BioFire Defense, received emergency use authorization from the U.S. Food and Drug Administration (FDA) for its BIOFIRE COVID-19 test to detect SARS-CoV-2 in CLIA (Clinical Laboratory Improvement Amendments) moderate and high complexity clinical laboratories. The BIOFIRE COVID-19 test detects SARS-CoV-2 from a nasopharyngeal swab in transport media in about 45 minutes.

Global Bacterial & Viral Specimen Collection Market- Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic has affected several markets across the globe. The COVID-19 pandemic has affected the demand and supply of healthcare products in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and due to its financial impact on firms and financial markets.

However, impact of the coronavirus (COVID-19) pandemic is expected to drive the growth of the global bacterial & viral specimen collection market during the forecast period, owing to the research and development activities by market players. For instance, on July 15, 2020, the Centers for Disease Control and Prevention (CDC) awarded Vysnova Partners Inc., Wake Forest Baptist Health, and several other health organizations a US$ 54 million contract to coordinate public health research on COVID-19 in the U.S. The organizations collaborated on a multi-site prospective study to answer key epidemiological and clinical questions about the novel coronavirus. As part of a two-year contract, these teams will study blood samples collected from patients and medical personnel involved in the medical system in the Southeast and Mid-Atlantic regions of the U.S.

Browse 49 Market Data Tables and 39 Figures spread through 217 Pages and in-depth TOC on Global Bacterial & Viral Specimen Collection Market, by Product Type (Bacterial Specimen Collection (Swabs, Bacterial Transport Media, Blood Collection Kits, and Others), Viral Specimen Collection (Swabs, Viral Transport Media, Blood Collection Kits, and Others)), by Application (Diagnostics and Research), by End User (Hospitals, Clinics, Diagnostic Laboratories, Research or Academic Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),

To know the latest trends and insights prevalent in the Global Bacterial & Viral Specimen Collection Market, click the link below:

 https://www.coherentmarketinsights.com/market-insight/bacterial-and-viral-specimen-collection-market-4753

Key Takeaways of the Global Bacterial & Viral Specimen Collection Market:

  • The global bacterial & viral specimen collection market is expected to exhibit a CAGR of 14% over the forecast period (2021-2028). North America is expected to account for major market share over the forecast period (2021-2028) owing to the rising adoption of inorganic growth strategies such as distribution agreement, collaboration, and acquisition by market players. For instance, on May 6, 2021, Technimark, a healthcare solutions provider, collaborated with Rhinostics, a commercial company, and iMFLUX, a P&G subsidiary, to manufacture, package, and distribute individually packaged medical-grade polypropylene nasal swabs to assist healthcare professionals and researchers in detecting and diagnosing potential infections such as COVID-19.
  • Some of the major players operating in the global bacterial & viral specimen collection market include Puritan Medical Products, COPAN Diagnostics, Becton Dickinson and Company, Thermo Fisher Scientific, Inc., Quidel Corporation, Longhorn Vaccines and Diagnostics LLC, Trinity Biotech, HiMedia Laboratories, Hardy Diagnostics, VIRCELL S.L., DiaSorin, and Titan Biotech.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.